methylene blue has been researched along with atorvastatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amalvict, R; Baret, E; Briolant, S; Charras, S; Dormoi, J; Feraud, M; Huyghues des Etages, E; Pascual, A; Pradines, B | 1 |
| Briolant, S; Desgrouas, C; Dormoi, J; Pradines, B | 1 |
| Mirzaei-Kalar, Z | 1 |
3 other study(ies) available for methylene blue and atorvastatin
| Article | Year |
|---|---|
Proveblue (methylene blue) as an antimalarial agent: in vitro synergy with dihydroartemisinin and atorvastatin.
Topics: Antimalarials; Artemisinins; Atorvastatin; Drug Interactions; Heptanoic Acids; Inhibitory Concentration 50; Methylene Blue; Plasmodium falciparum; Pyrroles | 2012 |
Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model.
Topics: Animals; Antimalarials; Atorvastatin; Disease Models, Animal; Drug Synergism; Female; Heptanoic Acids; Kaplan-Meier Estimate; Malaria, Cerebral; Methylene Blue; Mice; Mice, Inbred C57BL; Parasitemia; Pyrroles | 2013 |
In vitro binding interaction of atorvastatin with calf thymus DNA: multispectroscopic, gel electrophoresis and molecular docking studies.
Topics: Atorvastatin; Binding, Competitive; Bisbenzimidazole; DNA; Electrophoresis, Gel, Two-Dimensional; Methylene Blue; Molecular Docking Simulation; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Viscosity | 2018 |